Extended-release or immediate-release tablets containing pramipexole dihydrochloride for neurological conditions. Manufactured for B2B procurement by neurology departments in hospitals, outpatient clinics, and pharmacies from pharmaceutical suppliers in the movement disorder treatment segment.